Search

Sartorius Stedim Biotech.

Chiusa

SettoreFinanza

212.6 -0.47

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

212

Massimo

217

Metriche Chiave

By Trading Economics

Entrata

4.9M

93M

Vendite

4.2M

766M

P/E

Media del settore

66.977

20.954

EPS

1.25

Rendimento da dividendi

0.35

Margine di Profitto

12.146

Dipendenti

10,477

EBITDA

9.2M

240M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+11.21% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

0.35%

4.63%

Utili prossimi

22 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

2.1B

20B

Apertura precedente

213.07

Chiusura precedente

212.6

Notizie sul Sentiment di mercato

By Acuity

64%

36%

328 / 438 Classifica in Finance

Sartorius Stedim Biotech. Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

25 set 2026, 23:51 UTC

News

CDW Corp completed its acquisition of Lovelytics, enhancing its Services and Solutions portfolio, as shares advanced in after-market trading.

25 set 2026, 23:51 UTC

News

AbbVie Inc received FDA approval for Juvmo (Tavapadon), a Parkinson's treatment, contributing to a modest rise in shares during after-market trading.

25 set 2026, 23:35 UTC

News

DICK'S Sporting Goods faces two class action lawsuits alleging misleading financial statements, contributing to a modest decline in after-market trading.

25 set 2026, 23:15 UTC

News

Skyworks Solutions Inc. has extended the expiration date for Qorvo's senior notes exchange offers to October 2, 2026, with shares modestly higher in after-market trading.

25 set 2026, 23:05 UTC

News

PepsiCo plans to raise prices on select chips and sodas by late 2026 or early 2027 due to inflation and rising commodity costs, with stock roughly flat in after-market trading.

25 set 2026, 23:05 UTC

News

Vicor Corp raised its third-quarter revenue growth outlook to over 20%, doubling its previous forecast, following a new OEM licensing agreement. Shares advanced in after-market trading.

25 set 2026, 23:05 UTC

News

Moody's affirmed BJ's Wholesale Club's Ba1 rating and revised its outlook to positive, contributing to the asset's modest rise in after-market hours.

25 set 2026, 23:05 UTC

News

Coca-Cola Consolidated Inc appointed Rob Gehring to lead North American operations, effective December 1, as the stock trades lower in after-market hours.

25 set 2026, 23:05 UTC

News

Synopsys Inc is higher in after-market trading following HSBC's new price target of $700, citing AI's potential to enhance revenue capabilities.

25 set 2026, 23:05 UTC

Event
News

Merck & Co. has withdrawn its Biologics License Application for ifinatamab deruxtecan after the FDA indicated insufficient trial data, with shares trading lower in after-market hours.

25 set 2026, 23:05 UTC

News

Monster Beverage shares are modestly lower in after-market trading following CEO Rob Gehring's resignation announcement effective November 30, 2026.

25 set 2026, 23:05 UTC

News

McDonald's Corp plans an $8.5 billion menu overhaul to introduce healthier options, with shares edging higher in after-market trading.

25 set 2026, 23:01 UTC

News

Kodiak Sciences Inc. shares rose in after-market trading as the company announced topline results from its DAYBREAK Phase 3 study will be released on September 28, 2026.

25 set 2026, 23:01 UTC

News

Chevron Corp's shares rose in after-market trading as the company accelerates plans to export gas from Cyprus's Aphrodite field through Egypt's LNG facilities.

25 set 2026, 23:01 UTC

News

Marathon Petroleum's stock is higher in after-market hours as the White House reviews a potential diesel export ban that could impact earnings.

25 set 2026, 23:01 UTC

News

PayPal shares rose in after-market hours amid speculation of a potential all-stock takeover and Deutsche Bank's price target increase to $55 from $50.

25 set 2026, 22:50 UTC

News

S&P Global Ratings downgraded Cable One's credit rating to 'B+' amid increased competition, but the stock has advanced in after-market trading following five consecutive lower sessions.

25 set 2026, 22:45 UTC

News

Viatris Inc is seeing a modest increase in after-market trading after filing a lawsuit against Novo Nordisk over its planned generic Wegovy.

25 set 2026, 22:15 UTC

News

Fox Factory Holding Corp. completed the $225 million sale of Marucci Sports, reducing leverage and interest expenses, leading to higher shares in after-market hours.

25 set 2026, 22:01 UTC

News

S&P Global Ratings upgraded Rithm Capital Corp's credit rating to 'B+' as the firm diversifies revenue, with assets under management rising to $61 billion.

25 set 2026, 21:02 UTC

News

The New York Times Company declared a quarterly dividend of $0.23 per share, while the stock traded modestly lower in after-market hours.

25 set 2026, 21:01 UTC

News

Best Buy Co., Inc. plans to sell debt securities, contributing to a modest decline in after-market trading, with shares lower since Friday's close.

25 set 2026, 20:08 UTC

Social Media
News

Moderna Inc's stock advanced following CEO Stéphane Bancel's comments on focusing on cancer vaccines and recent positive trial results for its melanoma vaccine.

25 set 2026, 20:08 UTC

Social Media
News

Apple shares are advancing as Bernstein maintains a Buy rating with a $370 price target, despite lowering EPS estimates for Q1 to $2.87.

25 set 2026, 20:08 UTC

News

ON Semiconductor Corp shares are sharply higher, driven by the launch of its Embedded Power Platform and strengthened partnerships in automotive and AI sectors.

25 set 2026, 20:08 UTC

News

C3.ai Inc shares declined modestly as options sentiment remained mixed, with a put/call ratio of 0.33 and implied volatility in the lowest 10% of observations.

25 set 2026, 20:08 UTC

News

Snowflake Inc. shares are advancing as the company partners with CrowdStrike to integrate its AI-native Falcon platform into the Snowflake Marketplace.

25 set 2026, 20:08 UTC

Correlated Moves
News

Box Inc shares fell as the resignation of Chief Accounting Officer Eli Berkovitch may have contributed to the stock's ongoing decline, marking six consecutive days lower.

25 set 2026, 20:08 UTC

Social Media
News

Amazon.com Inc. saw moderately bullish options activity, with calls outpacing puts and a put/call ratio of 0.43, amid rising sentiment for October call options.

25 set 2026, 20:08 UTC

News

Aflac shares fell today as Japan Post Holdings sold 12.2k shares, contributing to a price move slightly below Thursday's close.

Confronto tra pari

Modifica del prezzo

Sartorius Stedim Biotech. Previsione

Obiettivo di Prezzo

By TipRanks

11.21% in crescita

Previsioni per 12 mesi

Media 240 EUR  11.21%

Alto 260 EUR

Basso 210 EUR

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Sartorius Stedim Biotech. - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

5 ratings

5

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

328 / 438 Classifica in Finanza

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.